Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

60.44
+0.69501.16%
Volume:208.11K
Turnover:12.54M
Market Cap:10.04B
PE:-17.37
High:60.62
Open:60.60
Low:59.70
Close:59.74
52wk High:86.74
52wk Low:41.71
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.75
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:22.84
PE(LYR):-25.38

Loading ...

Jefferies Remains a Buy on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jun 15

Ionis posts presentation on olezarsen-triglyceride reductions in severe hypertriglyceridemia

Reuters
·
Jun 15

Ionis posts ENDO 2026 presentation on olezarsen pancreatitis prevention in severe hypertriglyceridemia

Reuters
·
Jun 15

Ionis posts CORE-TIMI severe hypertriglyceridemia olezarsen data presentation

Reuters
·
Jun 13

Ionis shares 24-month extension data on olezarsen in severe hypertriglyceridemia study

Reuters
·
Jun 13

Fonds de solidarité FTQ joins $20 million CELYSTRA Pharma financing round

Reuters
·
Jun 09

Ionis Pharmaceuticals director Peter N. Reikes files initial beneficial ownership statement

Reuters
·
Jun 09

Ionis Pharmaceuticals Adds Veteran Leader to Board

TIPRANKS
·
Jun 09

Ionis adds former Alexion CEO Ludwig Hantson to board

Reuters
·
Jun 09

BRIEF-Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors

Reuters
·
Jun 08

Ionis Announces Appointment of Ludwig Hantson, Ph.d. to Board of Directors

THOMSON REUTERS
·
Jun 08

Ionis Pharmaceuticals (IONS) Receives a Buy from Guggenheim

TIPRANKS
·
Jun 06

Ionis posts presentation for 2026 annual shareholders meeting

Reuters
·
Jun 05

Ionis director Spencer R. Berthelsen disposes of 8,000 common shares for $605,360

Reuters
·
Jun 04

Ionis Pharmaceuticals Price Target Maintained With a $125.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 01

Ionis Pharmaceuticals: Advancing Pipeline, HBV Phase III Success, and Robust Catalyst Flow Underpin Buy Rating

TIPRANKS
·
May 28

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

TIPRANKS
·
May 28

Ionis Partner GSK Announces Bepirovirsen Achieves Unprecedented Functional Cure Rates With Potential to Redefine Treatment for Chronic Hepatitis B

THOMSON REUTERS
·
May 28

A New, Powerful Cholesterol-Lowering Drug Is on the Horizon -- WSJ

Dow Jones
·
May 28

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20